Connection

AHMED ELKHANANY to Humans

This is a "connection" page, showing publications AHMED ELKHANANY has written about Humans.
Connection Strength

0.071
  1. Therapeutic Clinical Trial Eligibility and Enrollment among Women with Breast Cancer: Implications for Understanding Trial Disparities. Ann Surg Oncol. 2025 Mar; 32(3):2038-2044.
    View in: PubMed
    Score: 0.006
  2. Increasing inclusion and equity for Black women in breast cancer clinical trials. Clin Adv Hematol Oncol. 2024 May; 22(4):175-182.
    View in: PubMed
    Score: 0.006
  3. Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2. Ann Oncol. 2023 12; 34(12):1131-1140.
    View in: PubMed
    Score: 0.006
  4. Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model. JCO Clin Cancer Inform. 2023 06; 7:e2200164.
    View in: PubMed
    Score: 0.006
  5. A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast Cancer Res Treat. 2023 Apr; 198(2):217-229.
    View in: PubMed
    Score: 0.005
  6. Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2023 Feb; 197(3):673-681.
    View in: PubMed
    Score: 0.005
  7. Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion. J Natl Cancer Inst. 2021 08 02; 113(8):1036-1043.
    View in: PubMed
    Score: 0.005
  8. Disparities in Breast Cancer Associated With African American Identity. Am Soc Clin Oncol Educ Book. 2021 Jun; 41:e29-e46.
    View in: PubMed
    Score: 0.005
  9. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 01 06; 19(1):77-102.
    View in: PubMed
    Score: 0.005
  10. Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer. Int J Mol Sci. 2020 Jun 30; 21(13).
    View in: PubMed
    Score: 0.005
  11. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. J Natl Compr Canc Netw. 2020 04; 18(4):380-391.
    View in: PubMed
    Score: 0.004
  12. Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast Cancer Res Treat. 2019 Dec; 178(3):523-533.
    View in: PubMed
    Score: 0.004
  13. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer. Breast Cancer Res Treat. 2018 01; 167(1):89-99.
    View in: PubMed
    Score: 0.004
  14. GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways. PLoS One. 2014; 9(12):e114409.
    View in: PubMed
    Score: 0.003
  15. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer. 2013 Mar 01; 132(5):1201-12.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.